DPP4i vs placebo
Heart failure hospitalisation (RR) · CVD (ASCVD, HF, or both)
DPP4i showed no clear difference in hospitalisation for HF compared with placebo (moderate certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 0.99 [0.8, 1.23]4 studies · 42334 participantsModerate